Auranofin inhibits the induction of interleukin 1beta and tumor necrosis factor alpha mRNA in macrophages

J Bondeson, Roger Sundler

Research output: Contribution to journalArticlepeer-review

Abstract

Gold compounds are widely used in the treatment of rheumatoid arthritis, but their mechanisms of action remain unclear. We demonstrate here that auranofin (AF) (0.1-3 microM), but neither the hydrophilic gold compounds aurothiomalate (ATM) and aurothioglucose nor methotrexate or D-penicillamine, inhibits the induction of interleukin 1 beta and tumor necrosis factor (TNF) alpha mRNA and protein by either zymosan, lipopolysaccharide (LPS), or various bacteria in mouse macrophages. The auranofin-mediated inhibition of the induction of TNF-alpha mRNA was stronger than that of interleukin (IL) 1 beta mRNA. AF, but not the other drugs, also inhibited zymosan-induced mobilization of arachidonate. The fact that AF inhibited the induction of mRNA for both these proinflammatory cytokines, irrespective of which stimulus was used, may indicate that it affects some common signal transduction step vital to their induction.
Original languageEnglish
Pages (from-to)1753-9
JournalBiochemical Pharmacology
Volume50
Issue number11
Publication statusPublished - 1995

Subject classification (UKÄ)

  • Basic Medicine

Fingerprint

Dive into the research topics of 'Auranofin inhibits the induction of interleukin 1beta and tumor necrosis factor alpha mRNA in macrophages'. Together they form a unique fingerprint.

Cite this